NEVICON SA

NEVICON SA — Nebivolol 5 mg + S(-) Amlodipine 2.5 mg Tablets

Overview

NEVICON SA is a combination antihypertensive medication containing Nebivolol 5 mg and S(-) Amlodipine 2.5 mg, formulated to provide comprehensive blood pressure control.

• Nebivolol is a beta-1 selective blocker that reduces heart rate and cardiac workload.

• S(-) Amlodipine is a calcium channel blocker that relaxes blood vessels, improving blood flow.

Together, this combination effectively manages hypertension, supports cardiovascular health, and reduces the risk of heart attack and stroke.

---

Composition

Each tablet contains:

• Nebivolol 5 mg – Beta-1 selective adrenergic blocker that decreases heart rate and cardiac output.

• S(-) Amlodipine 2.5 mg – Calcium channel blocker that relaxes vascular smooth muscles to lower blood pressure.

(Excipients q.s., as per approved formulation.)

---

Dosage Form

• Tablet

---

Therapeutic Class

• Antihypertensive / Beta-Blocker + Calcium Channel Blocker Combination

---

Indications

NEVICON SA Tablets are indicated for:

• Management of hypertension (high blood pressure)

• Patients requiring combination therapy for optimal blood pressure control

• Reduction of cardiovascular risk in high-risk hypertensive patients

---

Mechanism of Action

• Nebivolol selectively blocks beta-1 receptors, reducing heart rate, cardiac output, and myocardial oxygen demand.

• S(-) Amlodipine inhibits calcium influx in vascular smooth muscles, leading to vasodilation and reduced vascular resistance.

• The combination provides synergistic antihypertensive effects by targeting both cardiac and vascular mechanisms, ensuring effective blood pressure control.

---

Dosage and Administration

• Recommended Dose: As prescribed by the physician, usually once daily

• Route: Oral

• Duration: Long-term therapy as advised by a healthcare provider

Note: Regular monitoring of blood pressure, heart rate, and cardiovascular health is recommended.

---

Benefits

• Provides comprehensive blood pressure management

• Reduces risk of heart attack, stroke, and cardiovascular complications

• Combines dual mechanisms for enhanced efficacy

• Convenient once-daily tablet improves patient adherence

---

Side Effects

NEVICON SA is generally well tolerated. Possible side effects include:

• Dizziness or lightheadedness

• Fatigue or tiredness

• Swelling of ankles or feet

• Mild gastrointestinal discomfort (nausea, constipation)

• Rarely, bradycardia (slow heart rate) or hypotension

Consult your physician if side effects persist or worsen.

---

Precautions

• Use with caution in heart failure, severe kidney or liver impairment

• Avoid abrupt discontinuation of therapy

• Not recommended during pregnancy or lactation unless prescribed

• Inform your doctor about other medications to prevent drug interactions

---

Storage

Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.

---

Key Product Information

• Brand Name: NEVICON SA

• Composition: Nebivolol 5 mg + S(-) Amlodipine 2.5 mg

• Dosage Form: Tablet

• Therapeutic Class: Antihypertensive / Beta-Blocker + Calcium Channel Blocker

• Manufacturer: [Insert Company Name]

• Packaging: [Example: 10×10 Tablets / Strip]

---

Why Choose NEVICON SA

• Effective dual-action blood pressure control

• Reduces cardiovascular and cerebrovascular risks

• Convenient once-daily dosing for better compliance

• Manufactured under strict GMP-certified quality standards

---

Conclusion

NEVICON SA (Nebivolol 5 mg + S(-) Amlodipine 2.5 mg Tablets) offers comprehensive, dual-action management of hypertension. By combining a beta-blocker and calcium channel blocker, it helps control blood pressure, protect heart health, and reduce cardiovascular risks, supporting long-term wellness.